Vascular endothelial growth factor (VEGF) appears to be an important mediator of pathologic retinal angiogenesis. In understanding the mechanisms of pathologic retinal neovascularization, we found that VEGF activates PLD1 in human retinal microvascular endothelial cells, and this event is dependent on Src. In addition, VEGF activates protein kinase C-γ (PKCγ) via Src-dependent PLD1 stimulation. Inhibition of Src, PLD1, or PKCγ via pharmacologic, dominant negative mutant, or siRNA approaches significantly attenuated VEGF-induced human retinal microvascular endothelial cell migration, proliferation, and tube formation. Hypoxia also induced Src-PLD1-PKCγ signaling in retina, leading to retinal neovascularization. Furthermore, siRNA-mediated downregulation of VEGF inhibited hypoxia-induced Src-PLD1-PKCγ activation and neovascularization. Blockade of Src-PLD1-PKCγ signaling via the siRNA approach also suppressed hypoxia-induced retinal neovascularization. Thus, these observations demonstrate, for the first time, that Src-dependent PLD1-PKCγ activation plays an important role in pathologic retinal angiogenesis. © 2010 by The American Society of Hematology.
CITATION STYLE
Zhang, Q., Wang, D., Kundumani-Sridharan, V., Gadiparthi, L., Johnson, D. A., Tigyi, G. J., & Rao, G. N. (2010). PLD1-dependent PKCγ activation downstream to Src is essential for the development of pathologic retinal neovascularization. Blood, 116(8), 1377–1385. https://doi.org/10.1182/blood-2010-02-271478
Mendeley helps you to discover research relevant for your work.